A novel mechanism for macrophage pyroptosis in rheumatoid arthritis induced by Pol β deficiency

Lili Gu1, Yuling Sun1, Ting Wu1

  • 1Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, 1 Wen Yuan Road, Nanjing, 210023, China.

Insights

DNA polymerase β deficiency worsens rheumatoid arthritis by increasing macrophage pyroptosis via the cGAS-STING-NF-κB pathway. Restoring Pol β may offer a therapeutic strategy for this chronic autoimmune disease.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation.
  • Macrophage pyroptosis, a pro-inflammatory cell death, is crucial in RA pathogenesis.
  • The precise mechanisms driving pyroptosis in RA remain unclear.

Purpose of the Study:

  • To investigate the role of DNA polymerase β (Pol β) in rheumatoid arthritis.
  • To elucidate the molecular mechanisms linking Pol β to macrophage pyroptosis in RA.

Main Methods:

  • Assessed Pol β expression in peripheral blood mononuclear cells (PBMCs) from RA patients and collagen-induced arthritis (CIA) mice.
  • Utilized Pol β knockout and overexpression models in vitro and in vivo (CIA mice).
  • Analyzed DNA damage, cytosolic dsDNA leakage, and the cGAS-STING-NF-κB signaling pathway.

Main Results:

  • Pol β expression was significantly reduced in active RA patients and CIA mice.
  • Pol β deficiency exacerbated RA incidence, macrophage infiltration, and bone destruction in CIA models.
  • Pol β deficiency enhanced LPS/ATP-induced macrophage pyroptosis, leading to DNA damage, dsDNA leakage, and cGAS-STING-NF-κB pathway activation.

Conclusions:

  • DNA polymerase β plays a critical role in regulating macrophage pyroptosis in rheumatoid arthritis.
  • Pol β deficiency promotes RA development by activating the cGAS-STING-NF-κB pathway, increasing inflammatory cytokine production.
  • Findings offer insights into RA pathogenesis and potential therapeutic targets related to Pol β and pyroptosis.